Infinity Pharmaceuticals Inc
XBER:I3F
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Infinity Pharmaceuticals Inc
XBER:I3F
|
US |
|
Q
|
Quebec Nickel Corp
F:7IB
|
CA |
|
P
|
PCCW Ltd
OTC:PCWLF
|
HK |
|
Provexis PLC
F:NZCA
|
UK |
|
P
|
Pegasus Resources Inc
OTC:SLTFF
|
CA |
|
Polar Capital Holdings PLC
F:XZF
|
UK |
Dividends
Dividend Yield
Infinity Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Infinity Pharmaceuticals Inc
I3F have decreased by 0%.
Payout Ratio
Infinity Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for I3F is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
I3F Price
Infinity Pharmaceuticals Inc
| Average Annual Return | -35.76% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -100% |
| Market Capitalization | 91 EUR |
| Shares Outstanding | 1 010 400 910 |
| Percentage of Shares Shorted |
N/A
|
